Title:
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
Document Type and Number:
WIPO Patent Application WO/2016/082789
Kind Code:
A1
Abstract:
Described herein are neuroactive steroids of the Formula (II) : or a pharmaceutically acceptable salt thereof; wherein A, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5, R6 and ----- are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e. g., such for inducing sedation and/or anesthesia.
More Like This:
Inventors:
BOTELLA GABRIEL MARTINEZ (US)
HARRISON BOYD L (US)
ROBICHAUD ALBERT JEAN (US)
SALITURO FRANCESCO G (US)
BERESIS RICHARD THOMAS (CN)
HARRISON BOYD L (US)
ROBICHAUD ALBERT JEAN (US)
SALITURO FRANCESCO G (US)
BERESIS RICHARD THOMAS (CN)
Application Number:
PCT/CN2015/095765
Publication Date:
June 02, 2016
Filing Date:
November 27, 2015
Export Citation:
Assignee:
SAGE THERAPEUTICS INC (US)
BOTELLA GABRIEL MARTINEZ (US)
HARRISON BOYD L (US)
ROBICHAUD ALBERT JEAN (US)
SALITURO FRANCESCO G (US)
BERESIS RICHARD THOMAS (CN)
BOTELLA GABRIEL MARTINEZ (US)
HARRISON BOYD L (US)
ROBICHAUD ALBERT JEAN (US)
SALITURO FRANCESCO G (US)
BERESIS RICHARD THOMAS (CN)
International Classes:
C07J3/00; A61K31/56; A61P25/00; A61P25/08; C07J17/00; C07J43/00
Domestic Patent References:
WO2014169831A1 | 2014-10-23 | |||
WO1995021617A1 | 1995-08-17 | |||
WO2014169832A1 | 2014-10-23 | |||
WO2006037016A2 | 2006-04-06 | |||
WO2014071449A1 | 2014-05-15 |
Other References:
See also references of EP 3224269A4
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (Building 110 Caihefang Road, Haidian District, Beijing 0, CN)
Download PDF: